Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known which chemotherapy regimen is more effective in treating women after surgery for
breast cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of paclitaxel, epirubicin,
and cyclophosphamide with or without gemcitabine in treating women who have undergone surgery
for breast cancer.